Emily Pimblett

Insider Reports History

Location
Redmond, WA
Signature
/s/ Emily Pimblett
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Emily Pimblett:

Company Role Class Num Shares Value Price $ Report Date Ownership
Climb Bio, Inc. SVP, Finance & CAO Restricted Stock Units 15,000 $40,400 $2.02 18 Jun 2025 Direct
Climb Bio, Inc. SVP, Finance & CAO Common Stock 18,888 $23,421 $1.24 20 Jun 2025 Direct
Climb Bio, Inc. SVP, Finance & CAO Stock Option (Right to Buy) 100,000 13 Jan 2025 Direct

Insider Reports Filed by Emily Pimblett

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLYM Climb Bio, Inc. 18 Jun 2025 3 -$1,540 4 SVP, Finance & CAO 20 Jun 2025, 16:20
CLYM Climb Bio, Inc. 18 Mar 2025 3 -$1,571 4 SVP, Finance & CAO 20 Mar 2025, 17:21
CLYM Climb Bio, Inc. 13 Jan 2025 1 $0 4 SVP, Finance and CAO 15 Jan 2025, 16:15
CLYM Climb Bio, Inc. 18 Dec 2024 3 -$2,495 4 CHIEF ACCOUNTING OFFICER 20 Dec 2024, 16:15
CLYM Eliem Therapeutics, Inc. 18 Sep 2024 4 -$9,741 4 CHIEF ACCOUNTING OFFICER 20 Sep 2024, 21:53
CLYM Eliem Therapeutics, Inc. 18 Jun 2024 3 -$8,982 4 CHIEF ACCOUNTING OFFICER 21 Jun 2024, 14:57
CLYM Eliem Therapeutics, Inc. 18 Mar 2024 1 $0 4 CHIEF ACCOUNTING OFFICER 20 Mar 2024, 16:33
CLYM Eliem Therapeutics, Inc. 13 Mar 2023 0 $0 3 Chief Accounting Officer 21 Mar 2023, 10:21